Interaction databaseSupplement × PrescriptionReviewed May 2026

Iron and Levodopa/Carbidopa, timing-sensitive.

Iron chelates levodopa in the GI tract, forming insoluble complexes that significantly reduce levodopa absorption. This can worsen Parkinson's disease symptoms by reducing the amount of levodopa reaching the brain. Studies show iron can reduce levodopa bioavailability by up to 50%.

One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.

Sourcing standards·Evidence tiers

From the interaction database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.

At a glance

Substances
Iron and Levodopa/Carbidopa
Pair type
Timing Sensitive
Evidence (highest tier)
Strong
Source citations
5 sources
Stack Score effect
−5 to your Stack Score (per scored timing-sensitive row).
Scope
Supplement × Prescription
Last verified
May 30, 2026

Timing Sensitive · Strong evidence

Timing Sensitive

What is happening. Iron chelates levodopa in the GI tract, forming insoluble complexes that significantly reduce levodopa absorption. This can worsen Parkinson's disease symptoms by reducing the amount of levodopa reaching the brain. Studies show iron can reduce levodopa bioavailability by up to 50%.

Mechanism. Iron (Fe2+ and Fe3+) chelates levodopa through its catechol (dihydroxyphenyl) group, forming stable iron-levodopa complexes that are not absorbed in the intestine. Carbidopa does not prevent this chelation interaction.

Recommendation. Separate levodopa/carbidopa and iron supplements by at least 2 hours. Take iron at a different time of day than your Parkinson's medication. Inform your neurologist about iron supplementation.

Minimum separation. 120

Sources (5)
  1. Campbell NR, Hasinoff BB. Iron supplements: a common cause of drug interactions. Br J Clin Pharmacol. 1991;31(3):251-255. PMID 2054263
  2. Fischer JAJ, Cherian AM, Bone JN, Karakochuk CD. The effects of oral ferrous bisglycinate supplementation on hemoglobin and ferritin concentrations in adults and children: a systematic review and meta-analysis of randomized controlled trials. Nutrition Reviews. 2023. PMID 36728680
  3. Rehman T, Agrawal R, Ahamed F et al.. Optimal dose and duration of iron supplementation for treating iron deficiency anaemia in children and adolescents: A systematic review and meta-analysis. PLoS One. 2025. PMID 39951396
  4. Gutema BT, Sorrie MB, Megersa ND et al.. Effects of iron supplementation on cognitive development in school-age children: Systematic review and meta-analysis. PLoS One. 2023. PMID 37368919
  5. Hansen R, Sejer EPF, Holm C, Schroll JB. Iron supplements in pregnant women with normal iron status: A systematic review and meta-analysis. Acta Obstetricia et Gynecologica Scandinavica. 2023. PMID 37403900

Stack Score

How this pair moves the number.

Effect on the composite score

If both Iron and Levodopa/Carbidopa are in the same stack, this pair applies −5 to your Stack Score (per scored timing-sensitive row).

The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.

Check your full routine

One pair was the worked example. NutriStack runs every pair in your stack at once.

Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.